Sandra Manceau

Paris, 75015, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Base editing of β0-thalassemia mutations as a therapeutic strategy for severe β-hemoglobinopathies.

Base editing of β0-thalassemia mutations as a therapeutic strategy for severe β-hemoglobinopathies.

Journal: Science translational medicine
Published: November 26, 2025

Protein S Enhances the Phagocytosis of Phosphatidylserine-Exposing Erythrocytes: Implications in Sickle Cell Disease.

Protein S Enhances the Phagocytosis of Phosphatidylserine-Exposing Erythrocytes: Implications in Sickle Cell Disease.

Journal: American journal of hematology
Published: April 04, 2025

MMS22L is a novel key actor of normal and pathological erythropoiesis.

MMS22L is a novel key actor of normal and pathological erythropoiesis.

Journal: HemaSphere
Published: November 04, 2024

Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France.

Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France.

Journal: British journal of haematology
Published: September 30, 2024

Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell disease.

Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell disease.

Journal: Nature communications
Published: August 14, 2024

Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell disease.

Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell disease.

Journal: American journal of hematology
Published: July 03, 2024

Erythropoietin downregulates red blood cell clearance, increasing transfusion efficacy in severely anemic recipients.

Erythropoietin downregulates red blood cell clearance, increasing transfusion efficacy in severely anemic recipients.

Journal: American journal of hematology
Published: August 09, 2023

A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.

A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.

Journal: Haematologica
Published: April 11, 2023

Detrimental effects of sickle cell disease and hydroxycarbamide on ovarian reserve but uncertain impact on fertility.

Detrimental effects of sickle cell disease and hydroxycarbamide on ovarian reserve but uncertain impact on fertility.

Journal: Blood advances
Published: August 31, 2022

Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease.

Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease.

Journal: British journal of haematology
Published: July 13, 2022

Erythrocytic vacuoles that accumulate a fluorescent dye predict spleen size and function in sickle cell disease.

Erythrocytic vacuoles that accumulate a fluorescent dye predict spleen size and function in sickle cell disease.

Journal: American journal of hematology
Published: May 11, 2022

Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation.

Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation.

Journal: Blood
Published: April 18, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026